CMG Global Holdings’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
CMG Global Holdings's BMY Position: Q2 2026 in Review
CMG Global Holdings held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 3,869 shares worth $223K. The position accounts for 0.09% of the portfolio, ranked #99.
CMG Global Holdings first reported a position in BMY in Q1 2021 and has held it in 19 quarters since. The position peaked at $356K in Q2 2022. 1,158 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- CMG Global Holdings held 3,869 shares of Bristol-Myers Squibb worth $223K as of Q2 2026.
- CMG Global Holdings left its Bristol-Myers Squibb share count unchanged in Q2 2026.
- Bristol-Myers Squibb made up 0.09% of CMG Global Holdings's portfolio in Q2 2026, its #99 holding.
- CMG Global Holdings first reported a position in Bristol-Myers Squibb in Q1 2021 and has held it in 19 quarters since.
- CMG Global Holdings's Bristol-Myers Squibb position peaked at $356K in Q2 2022.
- 1,158 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on CMG Global Holdings's 13F filing for Q2 2026, filed 28 Jul 2026.